Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиRa Medical Systems Мультипликаторы 2011-2024 | RMED
Мультипликаторы по годам Ra Medical Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.0 | -0.3 | -0.5 | -2.2 | - | - | - | - | - | - | - |
P/S |
106.4 | 2.0 | 2.5 | 4.3 | 10.8 | - | - | - | - | - | - | - |
EPS |
-26.0 | -248.2 | -21.2 | -108.3 | -3.3 | -2.4 | - | - | - | - | - | - |
EV (Enterprise Value) |
-6.79 млн | -7.63 млн | -419 тыс. | 27.4 млн | 10.6 млн | -8.24 млн | - | - | - | - | - | - |
EBITDA per Share |
-25.7 | -274 | -19.8 | -106 | -82.7 | - | - | - | - | - | - | - |
EV/EBITDA |
0.3 | 0.3 | -0.3 | -0.1 | - | - | - | - | - | - | - | |
PEG |
- | -0.01 | 0.02 | 0.01 | - | - | - | - | - | - | - | |
P/B |
0.2 | 0.0 | 0.5 | 0.9 | 1.0 | - | - | - | - | - | - | - |
P/CF |
-0.1 | -0.0 | -0.4 | -0.9 | -3.5 | - | - | - | - | - | - | - |
ROE % |
-290.12 | -183.35 | -170.45 | -171.82 | -46.22 | - | - | - | - | - | - | - |
ROA % |
-159.57 | -119.13 | -107.80 | -129.21 | -41.65 | - | - | - | - | - | - | - |
ROCE % |
-291.16 | -214.04 | -140.44 | -154.91 | -45.77 | - | - | - | - | - | - | - |
Current Ratio |
2.2 | 2.9 | 3.6 | 5.3 | 11.6 | - | - | - | - | - | - | - |
DSO |
- | 2148.5 | 19.7 | 39.9 | 77.0 | - | - | - | - | - | - | - |
DIO |
- | 374.8 | 147.7 | 114.5 | 182.0 | - | - | - | - | - | - | - |
DPO |
1224.2 | 182.4 | 38.0 | 63.2 | 97.6 | - | - | - | - | - | - | - |
Операционный цикл |
- | 2523.3 | 167.4 | 154.4 | 259.0 | - | - | - | - | - | - | - |
Финансовый цикл |
-1224.2 | 2341.0 | 129.4 | 91.2 | 161.4 | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Ra Medical Systems
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | -4.36 | -0.26 | -0.27 | - | -33.58 | -1.28 | -2.48 | - | -3.26 | -10.71 | -13.98 | - | -1.3 | -1.16 | -1.16 | - | -0.59 | -1.03 | -0.34 | - | -0.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.39 | -1.17 | -12.3 | - | -4.02 тыс. | -253 | -265 | - | -48 тыс. | -1.43 тыс. | -2.2 тыс. | - | -2.37 | -9.42 | -13.1 | - | -1.29 | -1.15 | -1.15 | - | -0.56 | -1.02 | -0.33 | - | -0.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-238.66 | -267.92 | -347.58 | -154.70 | -174.65 | -156.52 | -94.92 | -92.41 | -129.19 | -146.03 | -169.21 | -121.06 | -173.61 | -189.36 | -187.12 | -142.43 | -149.63 | -104.30 | -71.26 | -23.83 | -1.24 | 28.55 | 41.14 | 22.59 | 22.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-174.44 | -195.84 | -250.18 | -109.18 | -125.05 | -113.66 | -72.89 | -62.52 | -85.78 | -93.17 | -105.44 | -76.56 | -116.08 | -132.33 | -136.36 | -107.11 | -113.60 | -80.58 | -57.61 | -21.47 | -36.73 | -45.50 | -34.16 | -15.26 | -15.26 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-262.62 | -288.36 | -348.26 | -155.03 | -189.34 | -185.42 | -130.70 | -111.36 | -146.86 | -148.05 | -164.20 | -120.17 | -173.23 | -190.79 | -189.25 | -144.46 | -151.67 | -105.82 | -72.10 | -23.82 | -1.25 | 28.53 | 41.11 | 22.57 | 22.57 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.0 | 3.0 | 3.8 | 2.2 | 3.5 | 3.1 | 4.2 | 2.9 | 4.9 | 3.7 | 2.5 | 2.7 | 2.7 | 2.7 | 2.7 | 4.0 | 4.0 | 4.0 | 4.0 | 10.1 | 10.1 | 10.1 | 10.1 | 0.6 | 0.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
56.6 | 94.6 | 54.2 | - | 55.4 | 392.4 | 238.3 | - | 2235.6 | 1966.9 | 7.5 | - | 13.1 | 24.1 | 34.0 | - | 37.6 | 33.3 | 55.0 | - | 58.4 | 97.5 | 86.5 | - | 18.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
935.3 | 840.8 | 319.4 | - | 12.2 | 761.8 | 982.1 | - | 615.8 | 401.1 | 103.9 | - | 99.6 | 173.4 | 143.9 | - | 104.5 | 92.7 | 114.5 | - | 149.5 | 193.3 | 204.1 | - | 78.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1961.9 | 4386.5 | 3066.0 | - | 268.4 | 1146.2 | 1036.9 | - | 300.5 | 180.2 | 48.1 | - | 33.5 | 44.6 | 60.6 | - | 57.6 | 51.1 | 62.4 | - | 80.2 | 103.7 | 96.2 | - | 28.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
991.9 | 935.4 | 373.6 | - | 67.6 | 1154.2 | 1220.4 | - | 2851.4 | 2368.1 | 111.4 | - | 112.7 | 197.6 | 177.9 | - | 142.1 | 126.0 | 169.5 | - | 207.8 | 290.7 | 290.6 | - | 97.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
-970.0 | -3451.1 | -2692.4 | - | -200.8 | 8.0 | 183.5 | - | 2550.9 | 2187.9 | 63.3 | - | 79.1 | 152.9 | 117.3 | - | 84.4 | 74.9 | 107.1 | - | 127.7 | 187.0 | 194.5 | - | 69.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD